Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lifecore Biomedical, Inc. \De\ (LFCR) Raw Materials (2016 - 2018)

Historic Raw Materials for Lifecore Biomedical, Inc. \De\ (LFCR) over the last 9 years, with Q4 2018 value amounting to $14.6 million.

  • Lifecore Biomedical, Inc. \De\'s Raw Materials rose 1041.65% to $14.6 million in Q4 2018 from the same period last year, while for Nov 2018 it was $14.6 million, marking a year-over-year increase of 1041.65%. This contributed to the annual value of $15.3 million for FY2018, which is 5048.24% up from last year.
  • Lifecore Biomedical, Inc. \De\'s Raw Materials amounted to $14.6 million in Q4 2018, which was up 1041.65% from $13.9 million recorded in Q3 2018.
  • Lifecore Biomedical, Inc. \De\'s 5-year Raw Materials high stood at $15.3 million for Q2 2018, and its period low was $4.2 million during Q4 2016.
  • Its 5-year average for Raw Materials is $11.2 million, with a median of $10.9 million in 2014.
  • In the last 5 years, Lifecore Biomedical, Inc. \De\'s Raw Materials plummeted by 6226.59% in 2016 and then soared by 21572.79% in 2017.
  • Quarter analysis of 5 years shows Lifecore Biomedical, Inc. \De\'s Raw Materials stood at $12.1 million in 2014, then dropped by 8.15% to $11.1 million in 2015, then plummeted by 62.27% to $4.2 million in 2016, then skyrocketed by 215.73% to $13.2 million in 2017, then grew by 10.42% to $14.6 million in 2018.
  • Its last three reported values are $14.6 million in Q4 2018, $13.9 million for Q3 2018, and $15.3 million during Q2 2018.